Use of a photosensitive agent capable of producing reactive oxygen species in the production of a drug for the photodynamic therapy of a disease related to stem cells, in vitro use, and pharmaceutical composition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10695428
APP PUB NO 20150335746A1
SERIAL NO

14442876

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of a photosensitive agent, or the precursor thereof, capable of producing reactive oxygen species (ROS) in the production of a drug that can be used for the photodynamic therapy (PDT)-based treatment of a disease related to a patient's stem cells, preferably epidermal stem cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS28006 MADRID
UNIVERSIDAD AUTONOMA DE MADRID28049 MADRID

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blazquez-Castro, Alfonso Madrid, ES 1 0
Calvo, Sanchez María Inmaculada Madrid, ES 1 0
Carrasco, Cerro Elisa Madrid, ES 1 0
Espada, Regalado Jesus Madrid, ES 2 0
Juarranz, De La Fuente Angeles Madrid, ES 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 30, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 30, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00